These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1463339)

  • 61. 5-fluorouracil, ifosfamide and mitomycin (FIM) combination for pancreatic-biliary tumors.
    Abad A; Rosell R; Barnadas A; Carles J; Ribelles N; Solano V
    Ann Oncol; 1991 Feb; 2(2):153. PubMed ID: 2054318
    [No Abstract]   [Full Text] [Related]  

  • 62. Failure to confirm major objective antitumor activity for streptozocin and doxorubicin in the treatment of patients with advanced islet cell carcinoma.
    Cheng PN; Saltz LB
    Cancer; 1999 Sep; 86(6):944-8. PubMed ID: 10491519
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mixed beam radiotherapy and combination chemotherapy in localized pancreatic adenocarcinoma-preliminary results.
    Bukowski RM; Gahbauer R; Rodriquez-Antunez A; Hermann R
    Int J Radiat Oncol Biol Phys; 1982 Jul; 8(7):1231-3. PubMed ID: 6214533
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Effect of cancer chemotherapy for unresectable cancer of the pancreas].
    Kinami Y; Konishi K; Shinmura K; Takada M; Sakuma H; Nagakawa T; Miyazaki I
    Nihon Gan Chiryo Gakkai Shi; 1982 Oct; 17(7):1835-40. PubMed ID: 6819330
    [No Abstract]   [Full Text] [Related]  

  • 65. [Adjuvant treatment in cancer of the stomach].
    Popowski G; Bleiberg H; Van Houtte P
    Acta Gastroenterol Belg; 1989; 52(3-4):382-8. PubMed ID: 2700274
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Combination chemotherapy for metastatic carcinoma of the ampulla of Vater--report of three cases.
    Bukowski RM; Hermann RE; Theodors A
    J Surg Oncol; 1984 Apr; 25(4):284-6. PubMed ID: 6232429
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Phase II trial of streptozotocin, mitomycin-C and 5-fluorouracil (SMF) in the treatment of advanced pancreatic cancer.
    Wiggans RG; Woolley PV; Macdonald JS; Smythe T; Ueno W; Schein PS
    Cancer; 1978 Feb; 41(2):387-91. PubMed ID: 147131
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Chemotherapy of pancreatic carcinoma.
    Harvey JH; Schein PS
    World J Surg; 1984 Dec; 8(6):935-9. PubMed ID: 6440373
    [No Abstract]   [Full Text] [Related]  

  • 69. Chemotherapy in the treatment of neuroendocrine malignant tumors.
    Rougier P; Mitry E
    Digestion; 2000; 62 Suppl 1():73-8. PubMed ID: 10940691
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Chemotherapy prolongs survival in inoperable pancreatic carcinoma.
    Palmer KR; Kerr M; Knowles G; Cull A; Carter DC; Leonard RC
    Br J Surg; 1994 Jun; 81(6):882-5. PubMed ID: 8044610
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Overview of chemotherapy for pancreatic cancer.
    Arbuck SG
    Int J Pancreatol; 1990; 7(1-3):209-22. PubMed ID: 2081925
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Influence of N-(o-methoxyphenyl)-maleimide on 5-fluorouracil cytotoxicity in Ehrlich (ascites) carcinoma.
    Ambaye RY; Indap MA
    Cancer Lett; 1991 Apr; 57(1):21-6. PubMed ID: 1902758
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cytology of solid and papillary epithelial neoplasms of the pancreas: a case report.
    Stachura J; Popiela T; Pietroń M; Tomaszewska R; Kulig J; Nowak K
    Diagn Cytopathol; 1988; 4(4):339-41. PubMed ID: 3254813
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Lack of efficacy of streptozocin and doxorubicin in patients with advanced pancreatic endocrine tumors.
    Vilar E; Tabernero J; Casado E; Macarulla T; Ramos FJ; Martinelli E; Saura C
    Am J Clin Oncol; 2005 Aug; 28(4):424. PubMed ID: 16062087
    [No Abstract]   [Full Text] [Related]  

  • 75. Lack of efficacy of streptozocin and doxorubicin in patients with advanced pancreatic endocrine tumors.
    McCollum AD; Kulke MH; Ryan DP; Clark JW; Shulman LN; Mayer RJ; Bartel S; Fuchs CS
    Am J Clin Oncol; 2004 Oct; 27(5):485-8. PubMed ID: 15596916
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Chemotherapy of gastrointestinal cancer.
    Moertel CG
    Clin Gastroenterol; 1976 Sep; 5(3):777-93. PubMed ID: 139219
    [No Abstract]   [Full Text] [Related]  

  • 77. Intracavitary chemotherapy.
    Markman M
    Crit Rev Oncol Hematol; 1985; 3(3):205-33. PubMed ID: 2412719
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Metastatic pancreatic neuroendocrine tumors and chemotherapy: evidences and perspectives].
    Gómez Raposo C; Gómez Senent S; González Barón M
    Med Clin (Barc); 2007 Mar; 128(9):357; author reply 357-8. PubMed ID: 17376367
    [No Abstract]   [Full Text] [Related]  

  • 79. [Evaluation of antitumor effect of chemotherapy for pancreatic cancer].
    Okada S
    Gan To Kagaku Ryoho; 1997 Nov; 24(14):2031-5. PubMed ID: 9388510
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Fluorouracil and mitomycin for pancreatic cancer.
    Bosch X
    Lancet Oncol; 2005 Sep; 6(9):644. PubMed ID: 16161265
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.